• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Biondvax Pharmaceuticals Ltd

+ Add to Watchlist

BNDX:IT

68.40 ILs 0.40 0.58%

As of 10:24:57 ET on 08/20/2014.

Snapshot for Biondvax Pharmaceuticals Ltd (BNDX)

Open: 68.20 Day's Range: 68.10 - 69.80 Volume: 13,914
Previous Close: 68.80 52wk Range: 56.00 - 85.00 1-Yr Rtn: -2.70%

Stock Chart for BNDX

No chart data available.
  • BNDX:IT 68.10
  • 1D
  • 1M
  • 1Y
68.80
Interactive BNDX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BNDX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TA-100 -
Earnings Per Share (ttm) -0.1532
Est. EPS -
Est. PEG Ratio -
Market Cap (M ILS) 37.13
Shares Outstanding (M) 54.28
30 Day Average Volume 46,826
Price/Book (mrq) 1.5136
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BNDX

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for BNDX

Biondvax Pharmaceuticals Limited is a pharmaceutical company that develops intra-nasal flu vaccines.

Ron BabecoffPresident/CEOUri Ben OrChief Financial Officer
Tammar Ben YedidyaChief Scientific OfficerShimon HassinChief Operating Officer
More Company Profile & Key Executives for BNDX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil